The MarketWatch News Department was not involved in the creation of this content. -- UK Market Entry: MHRA registration authorizes hp+detect(TM) for commercial sale in Great Britain -- Active ...
Celadon Pharmaceuticals Plc, a UK pharmaceutical company, gained MHRA registration for Good Manufacturing Practice (GMP) manufacture of their high-THC cannabis Active Pharmaceutical Ingredient (API).
Proposed changes may better align the system with international standards, though continued divergence between the UK and EU regulatory landscapes ...
London, 22 December 2022 - Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on the research, cultivation, manufacturing and sale of breakthrough cannabis-based ...
Active Commercialization: Biomerica is in active discussions with UK partners to access the diagnostic laboratory market and expects to provide further updates as agreements are finalized. Disease ...
Registration marks the Company’s entry into the UK market, where H. pylori affects an estimated 45% of the population across Europe’s five largest countries IRVINE, Calif., March 05, 2026 (GLOBE ...